Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-68.37	54.74	-173.06
Graham Fair Price	23.60	65.52	53.01
PEG	-41.76	-0.04	0.06
Price/Book	22.74	0.59	0.48
Price/Cash Flow	-87.21	15.67	-122.49
Prices/Earnings	-18.84	8.99	-11.08
Price/Sales	-1.07	6.49	6.56
Price/FCF	-87.21	15.67	-122.49
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	126.12	0.38	0.17
Operating Margin	351.45	0.40	-0.09
ROA	51.35	< 0.005	< 0.005
ROE	-0.01	0.02	51.22
ROIC	< 0.005	< 0.005	258.30
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.04	0.86	-95.03
Dividends QOQ	-0.02	-0.02	19.91
EBIT QOQ	-1.28	6.63	419.75
EPS QOQ	-1.71	2.38	39.36
FCF QOQ	-1.06	10.65	907.42
Revenue QOQ	-0.18	0.25	35.05
Naive Interpretation	member

03 - Financial Growth · Best

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-194.49	-679.24	-249.25
Days Sales Outstanding (DSO)	325.84	296.86	-8.89
Inventory Turnover	-0.46	-0.13	71.37
Debt/Capitalization	0.74	0.75	0.94
Quick Ratio	0.78	0.77	-0.82
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	107.58	108.14	0.51
Cash	271.18	275.22	1.49
Capex	-0.92	-0.84	8.99
Free Cash Flow	-0.42	4.05	864.36
Revenue	7.84	9.77	24.70
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.49	1.49	-0.17
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-133.67	40.57	-69.65
Naive Interpretation	Member

06 - Financial Health · Weak

Rating